Page 823 - First Aid for the USMLE Step 1 2020, Thirtieth edition [MedicalBooksVN.com]_Neat

INDEX INDEX 779

Leukocoria, 538 Linear viruses, 163 cystic fibrosis, 60 LPS endotoxin, 124, 131, 133, 145
Leukocyte adhesion deficiency, 117, Lines of Zahn, 672 hepatosteatosis, 72 LTB (Leukotriene B4), 406, 485
4
215 Lineweaver-Burk plot, 230 hereditary, 394 Lumbar puncture, 507, 521
Leukocyte alkaline phosphatase Linezolid, 193 ischemia in, 210 Lumbosacral radiculopathy, 455
(LAP), 406 highly resistant organisms, 198 metastases to, 223 Lumbrical muscles, 450
Leukocyte esterase, 181, 600 protein synthesis inhibition, 191 serum markers, 390 Klumpke palsy and, 448
Leukocytes Lingula (lung), 663 target cells in, 415 median and ulnar nerves, 447
extravasation, 214, 215 Linkage disequilibrium, 57 Wilson disease and, 395 Lumefantrine, 200
leukemias, 432 Liothyronine (T3), 354 Liver failure Lunate bone, 449
in urine, 181, 594, 600 Lipase Budd-Chiari syndrome and, 392 Lung abscesses, 685
Leukocytoclastic vasculitis, 173 pancreatic secretions, 373 movement disorder in, 519 Lung and chest wall expansion, 665
Leukocytosis, 213 in pancreatitis, 397 Liver fluke Lung cancer
diabetic ketoacidosis, 347 Lipid-lowering agents hyperbilirubinemia with, 393 asbestosis and, 677
nosocomial infections, 185 mechanism and adverse effects, as oncogenic microbe, 226 carcinogens causing, 225
Leukodystrophies, 494, 524 320–321 Liver function tests cisplatin/carboplatin for, 442
Leukoerythroblastic reaction, 424 Lipid metabolism cholestatic pattern of, 395 erlotinib for, 442
Leukopenias, 424 fatty acids, 73 serum markers for, 390 hypercalcemia and, 228
cytarabine, 440 Lipids Liver markers incidence/mortality in, 222
ganciclovir, 202 key enzymes in, 93 in alcohol use, 570 metastases to, 223
trimethoprim, 194 transport of, 92–93 Liver tumors, 392 non–small cell, 684
Leukoplakia, 479 Lipodystrophy Living wills, 266 oncogenes and, 224
Leukotrienes protease inhibitors, 203 Loa loa, 159 paraneoplastic syndromes and,
basophils and, 408 tesamorelin for, 328 Loading dose, 231 228
cortisol effects, 336 Lipofuscin, 211 Lobar pneumonia presentation and complications,
Levator veli palatini muscle, 620 Lipoic acid, 76 natural history of, 683 684
Levetiracetam, 544 Lipolysis organisms and characteristics, 683 small cell, 684
Levodopa, 548, 549 cortisol and, 336 physical findings with, 680 topotecan for, 442
Levofloxacin insulin and, 334 Lobular carcinoma (breast), 650 Lung diseases
fluoroquinolones, 195 sympathetic receptors and, 238 Local anesthetics, 550 obstructive, 674–675
Pseudomonas aeruginosa, 143 thyroid hormone and, 331 Localized amyloidosis, 212 restrictive, 675
Levomilnacipran, 575 Lipomas, 220 Locked-in syndrome Lungs
Levonorgestrel, 657 Lipophilic drug osmotic demyelination syndrome, anatomical relationships, 663
Levothyroxine, 354 drug metabolism of, 232 524 blood flow regulation, 297
Lewy bodies, 520, 521 Lipoprotein lipase, 93 stroke, 515 development of, 660
dementia, 521 Lipoproteins, 93 Locus ceruleus, 495 physical findings, 680
Leydig cells functions of, 94 Locus heterogeneity, 57 sclerosis of, 473
cryptorchidism, 651 Liposarcomas, 220 Löffler endocarditis, 308 transfusion-related injury, 114
endocrine function, 628, 638 Lipoteichoic acid Löffler medium, 126 Lung volumes, 664
genital embryology, 622 cytoplasmic membrane, 124 Corynebacterium diphtheriae, 139 Lung zones, 669
tumors of, 653 Liquefactive necrosis, 209 Lomustine, 441 Lupus
LFA-1 antigens, 215 Liraglutide, 353 Lone Star tick (disease vector), 149 autoimmune hemolytic anemia
Libido Lisch nodules, 525 Long-chain fatty acid (LCFA) and, 423
in geriatric patients, 270 Lisdexamfetamine, 572 metabolism of, 89 azathioprine for, 440
testosterone and, 636 Lisinopril, 610 Long QT syndrome drug-induced, 115
Libman-Sacks endocarditis, 470 Lispro, 352 congenital, 294 isoniazid, 197
Lice Lissencephaly, 491 ranolazine, 319 lymphopenia, 424
disease vectors, 149 Listeria monocytogenes sudden cardiac death, 304 marantic endocarditis in, 311
head/scalp, 161 β-hemolysis, 135 Long thoracic nerve microangiopathic hemolytic
treatment, 200 neonates, 182 arm abduction, 446 anemia,, 423
Lichen planus, 173, 475, 482 penicillins for, 188 neurovascular pairing, 455 nephritis, 470
Lichen sclerosus, 644 transmission of, 139 Loop diuretics, 608 neutropenia, 424
Lichen simplex chronicus, 644 Listeria spp for heart failure, 309 Lupus anticoagulant, 115
Liddle syndrome, 586 facultative intracellular organisms, toxicity of, 251 Lupus-like syndrome
markers in, 591 127 Loop of Henle, 608 α-methyldopa, 243
Lidocaine, 322, 550 intracellular organism, 127 Bartter syndrome and, 586 hydralazine, 318
Life support Lithium ethacrynic acid effect on, 608 procainamide, 322
withdrawal, 269 diabetes insipidus and, 249, 338 “loose associations,” 559 Lurasidone, 573
Li-Fraumeni syndrome hypothyroidism, 341 Looser zones (osteomalacia), 463 Luteal phase of menstrual cycle, 632
osteosarcomas, 465 mechanism and use, 574 Loperamide, 400, 551 Luteinizing hormone (LH)
tumor suppressor genes in, 46, 224 prenatal exposure, 298, 300 Lopinavir clomiphene effect, 656
Ligaments teratogenicity, 614 HIV therapy, 203 contraception, 657
female reproductive anatomy, 625 therapeutic index of, 234 Loratadine, 686 estrogen/progesterone, 630
gastrointestinal anatomy, 361 thyroid functions with, 249 Lorazepam hCG and, 617
Ligamentum arteriosum, 282 toxicity of, 569 alcohol withdrawal, 572 ovulation, 631
Ligamentum teres hepatis, 282, 361 Live attenuated vaccines, 111 Losartan, 610 PCOS, 645
Ligamentum venosum, 282 Liver Low birth weight, 635 premature ovarian failure, 636
Ligand receptors, 208 blood supply and innervation of, 364 Löwenstein-Jensen agar/medium, 126 secretion of, 327
Lightheadedness, 534 in gastrointestinal anatomy, 361 Lower esophageal sphincter (LES) sex development disorders, 639
Likelihood ratio (LR), 257 lipid transport and, 92 achalasia and, 376 signaling pathways of, 337
Limbic system, 499 tissue architecture, 367 in Barrett esophagus, 377 spermatogenesis, 628
Limited scleroderma (CREST Liver/biliary disease nitric oxide and, 371 testosterone, 658
syndrome), 115, 473 acanthocytes in, 414 Lower extremity nerves, 452–453 Lyme disease
Linagliptin, 353 alcoholic, 391 Lower left quadrant (LLQ) pain, 383 animal transmission, 149
Lindane, 200 anemia, 420 Lower motor neuron (LMN) lesions, AV block in, 295
Linea alba, 369 autoimmune, 389, 392, 395 530, 531 Borrelia burgdorferi, 146
Linear ulcers, 377 cirrhosis, 71, 80, 389 facial nerve, 532 ceftriaxone, 189

FAS1_2019_21_Index_749-806.indd 779 11/21/19 12:27 PM